Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner

Abstract

Bacterial dNKs efficiently activate nucleoside analogues in a species-specific manner. Therefore, nucleoside analogues have a potential to be employed as antibiotics in the fight against emerging multiresistant bacteria.